Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background Chronic sinonasal disease is common in asthma and associated with poor asthma control; however there are no long term trials addressing whether chronic treatment of sinonasal disease improves asthma control. Objective To determine if treatment of chronic sinonasal disease with nasal corticosteroids improves asthma control as measured by the Childhood Asthma Control Test (cACT) and Asthma Control Test (ACT) in children and adults respectively. Methods A 24 week multi-center randomized placebo controlled double-blinded trial of placebo versus nasal mometasone in adults and children with inadequately controlled asthma. Treatments were randomly assigned with concealment of allocation. Results 237 adults and 151 children were randomized to nasal mometasone versus placebo, 319 participants completed the study. There was no difference in the cACT (difference in change with mometasone – change with placebo [ΔM - ΔP]: -0.38, CI: -2.19 to 1.44, p = 0.68 ages 6 to 11) or the ACT (ΔM - ΔP: 0.51, CI: -0.46 to 1.48, p = 0.30, ages 12 and older) in those assigned to mometasone versus placebo. In children and adolescents, ages 6 to 17, there was no difference in asthma or sinus symptoms, but a decrease in episodes of poorly controlled asthma defined by a drop in peak flow. In adults there was a small difference in asthma symptoms measured by the Asthma Symptom Utility Index (ΔM - ΔP: 0.06, CI: 0.01 to 0.11, p <0.01) and in nasal symptoms (sinus symptom score ΔM - ΔP: -3.82, CI: -7.19 to- 0.45, p =0.03), but no difference in asthma quality of life, lung function or episodes of poorly controlled asthma in adults assigned to mometasone versus placebo. Conclusions Treatment of chronic sinonasal disease with nasal corticosteroids for 24 weeks does not improve asthma control. Treatment of sinonasal disease in asthma should be determined by the need to treat sinonasal disease rather than to improve asthma control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the asthma control test
Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., Murray, J. J., & Pendergraft, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.008 · Cited by 2,906
Schatz, M., Sorkness, C. A., Li, J. T., Marcus, P., Murray, J. J., Nathan, R. A., Kosinski, M., Pendergraft, T. B., & Jhingran, P. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.011 · Cited by 1,221
Segmental Bronchial Provocation Induces Nasal Inflammation in Allergic Rhinitis Patients
BRAUNSTAHL, G.-J., KLEINJAN, A., OVERBEEK, S. E., PRINS, J.-B., HOOGSTEDEN, H. C., & FOKKENS, W. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9906121 · Cited by 399
Rhinosinusitis in severe asthma
Bresciani, M., Paradis, L., Des Roches, A., Vernhet, H., Vachier, I., Godard, P., Bousquet, J., & Chanez, P. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.111593 · Cited by 345
Watson, W. T. A., Becker, A. B., & Simons, F. E. R. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90301-u · Cited by 336
Chronic sinusitis in severe asthma is related to sputum eosinophilia
ten Brinke, A., Grootendorst, D. C., Schmidt, J. T., de Bruïne, F. T., van Buchem, M. A., Sterk, P. J., Rabe, K. F., & Bel, E. H. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122458 · Cited by 311
Corren, J., Adinoff, A. D., Buchmeier, A. D., & Irvin, C. G. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90079-h · Cited by 290
Self-citationBousquet, J., Gaugris, S., Kocevar, V. S., Zhang, Q., Yin, D. D., Polos, P. G., & Bjermer, L. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02251.x · Cited by 201
Thomas, M., Kocevar, V. S., Zhang, Q., Yin, D. D., & Price, D. (2005) · Pediatrics · doi:10.1542/peds.2004-0067 · Cited by 145
Association between allergic rhinitis and hospital resource use among asthmatic children in Norway
Sazonov Kocevar, V., Thomas, J., Jonsson, L., Valovirta, E., Kristensen, F., Yin, D. D., & Bisgaard, H. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00712.x · Cited by 61
Cited by
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Eifan, A. O., & Durham, S. R. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12780 · Cited by 379
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
Chong, L. Y., Head, K., Hopkins, C., Philpott, C., Schilder, A. G., & Burton, M. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011996.pub2 · Cited by 192
Immunotherapy in allergic rhinitis and lower airway outcomes
Cardona, V., Luengo, O., & Labrador-Horrillo, M. (2017) · Allergy · doi:10.1111/all.12989 · Cited by 50
“Despite some data suggest a positive impact on asthma control by treating rhinitis (51, 52), others have not been able to show such effect (53, 54).”
BackgroundEifan, A. O., Orban, N. T., Jacobson, M. R., & Durham, S. R. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0339oc · Cited by 49
Metadata
- Authors
- Dixon, A. E., Castro, M., Cohen, R. I., Gerald, L. B., Holbrook, J. T., Irvin, C. G., Mohapatra, S., Peters, S. P., Rayapudi, S., Sugar, E. A., & Wise, R. A.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 135
- Issue
- 3
- Pages
- 701-709.e5
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2005538706
- Cited by
- 56
- References
- 10
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.